Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Norman Wolmark, MD
NSABP Foundation Inc
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
43 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arrowhead Regional Medical Center
Colton, California, United States
Recruiting - Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, United States
Recruiting - University of Florida Cancer Center at Orlando Health
Orlando, Florida, United States
Recruiting - Cancer Care Specialists of Central Illinois
Decatur, Illinois, United States
Recruiting - Edward Hospital Cancer Center
Naperville, Illinois, United States
Recruiting - Fort Wayne Medical Oncology and Hematology, Inc.
Fort Wayne, Indiana, United States
Recruiting - University of Iowa
Iowa City, Iowa, United States
Recruiting - University of Louisville Jg Brown Cancer Center
Louisville, Kentucky, United States
Recruiting - University Medical Center New Orleans
New Orleans, Louisiana, United States
Recruiting - Greater Baltimore Medical Center
Baltimore, Maryland, United States
Recruiting - St. Joseph Mercy Hospital
Ann Arbor, Michigan, United States
Recruiting - Henry Ford Hospital
Detroit, Michigan, United States
Recruiting - Genesys Hurley Cancer Institute
Flint, Michigan, United States
Recruiting - Herbert Herman Cancer Center, Sparrow Hospital
Lansing, Michigan, United States
Recruiting - Ascension St. Mary'S
Saginaw, Michigan, United States
Recruiting - Newark Beth Israel Medical Center
Newark, New Jersey, United States
Recruiting - University of Rochester - Wilmot Cancer Institute
Rochester, New York, United States
Recruiting - Strecker Cancer Center-Belpre
Belpre, Ohio, United States
Recruiting - Aultman Hospital
Canton, Ohio, United States
Recruiting - Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
Recruiting - Adena Regional Medical Center
Columbus, Ohio, United States
Recruiting - Arthur G. James Cancer Hospital & Richard Solove Research Institute
Columbus, Ohio, United States
Recruiting - Columbus Oncology & Hematology Associates Inc
Columbus, Ohio, United States
Recruiting - Doctors Hospital
Columbus, Ohio, United States
Recruiting - the Mark H. Zangmeister Center
Columbus, Ohio, United States
Recruiting - Dayton Clinical Oncology Program
Dayton, Ohio, United States
Recruiting - Dayton Physicians Llc
Dayton, Ohio, United States
Recruiting - Delaware Health Center
Delaware, Ohio, United States
Recruiting - Marietta Memorial Hospital Cancer Center
Marietta, Ohio, United States
Recruiting - Marion General Hospital
Marion, Ohio, United States
Recruiting - Knox Community Hospital
Mount Vernon, Ohio, United States
Recruiting - Licking Memorial Hospital
Newark, Ohio, United States
Recruiting - Southern Ohio Medical Center
Portsmouth, Ohio, United States
Recruiting - Genesis Health Care
Zanesville, Ohio, United States
Recruiting - Wellspan Health - York Cancer Center
York, Pennsylvania, United States
Recruiting - Harris Health Systems-Smith Clinic
Houston, Texas, United States
Recruiting - Lester and Sue Smith Breast Center
Houston, Texas, United States
Recruiting - Centra Lynchburg Hematology Oncology
Lynchburg, Virginia, United States
Recruiting - Bon Secours Richmond Community Hospital Medical Oncology Assoc.
Mechanicsville, Virginia, United States
Recruiting - Bon Secours St. Francis Medical Center
Midlothian, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 May 2018
- Primary completion
- 30 Oct 2023
- Completion
- 30 Oct 2023
- Last update posted
- 6 Mar 2023
- Registered enrollment
- 64
- Registry id
- NCT03412643
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.